Translational Development Acquisition (TDACW) Profit After Tax (2024 - 2026)
Translational Development Acquisition's (TDACW) quarterly Profit After Tax came in at $946982.0 in Q2 2026, down 41.66% on a YoY basis from $1.6 million in Q2 2025, and down 28.95% quarter-over-quarter from $1.3 million in Q1 2026.
Analysis
Translational Development Acquisition (TDACW) Profit After Tax (2024 - 2026) Analysis & Trends
Translational Development Acquisition (TDACW) has reported Profit After Tax for 3 consecutive years, with $946982.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Profit After Tax fell 41.66% year-over-year to $946982.0; the trailing twelve-month figure through Jun 2026 stood at $5.5 million (up 82.27% YoY), and the FY2025 full-year result was $6.4 million, up 9059.65% from the prior year.
- Profit After Tax declined to $946982.0 in Q2 2026 per TDACW's latest filing, from $1.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at $1.7 million in Q3 2025 and bottomed at -$61283.0 in Q3 2024.
- Historically, Profit After Tax has averaged $1.1 million across 3 years, with a median of $1.4 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Profit After Tax jumped 19939.5% in 2025, then slumped 41.66% in 2026.
- Over 3 years, Profit After Tax stood at -$8044.0 in 2024, then surged by 19939.5% to $1.6 million in 2025, then slumped by 40.66% to $946982.0 in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $946982.0, $1.3 million, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Evercore | 11.52 Bn | 9.43 Bn | 975.67 Mn | 106.50 Mn |
| 2 | Jefferies Financial | 11.24 Bn | -4.17 Bn | 3.09 Bn | 249.98 Mn |
| 3 | Houlihan Lokey | 9.53 Bn | 8.45 Bn | - | - |
| 4 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - | -8,222.00 |
| 5 | PJT Partners | 6.94 Bn | 6.99 Bn | 481.98 Mn | 81.29 Mn |
| 6 | Moelis | 6.06 Bn | 5.99 Bn | - | 55.13 Mn |
| 7 | Piper Sandler Companies | 5.20 Bn | 5.09 Bn | - | 70.10 Mn |
| 8 | Lazard | 4.97 Bn | 3.99 Bn | - | 13.73 Mn |
| 9 | BRBI BR Partners | 3.44 Bn | 3.32 Bn | 16.77 Mn | 6.93 Mn |
| 10 | Translational Development Acquisition | 52.67 Mn | 52.58 Mn | - | 946,982.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 946,982.00 |
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | -8,044.00 |
| Sep 30, 2024 | -61,283.00 |